Api Boost News Today : Breaking News, Live Updates & Top Stories | Vimarsana

However, a nearly 18% rise in expenses ate into the company s core profit margin, which contracted to 29% from 30.2% a year earlier.

United statesGlenmark pharmaAurobindo pharmaGlenmark life sciencesTorrent pharmaceuticalsLife sciencesGlenmark pharmaceuticalsIndia glenmark life sciencesLatin americaNifty pharmaMarket expertApi boost